描述
Gut microbiota composition analysis showing changes in bifidobacteria abundance following HMO supplementation in IBS patients. The data support HMO's ability to safely modulate fecal microbial populations.
Figure 2
ChartSource Paper
The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel …Cite This Figure
![Figure 2: Gut microbiota composition analysis showing changes in bifidobacteria abundance following HMO supplementation in IBS patients. The data support HMO's ability to safely modulate fecal microbial populations.]() > Source: Cristina Iribarren et al. "The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profile." *Nutrients*, 2021. PMID: [34836092](https://pubmed.ncbi.nlm.nih.gov/34836092/)
<figure> <img src="" alt="Gut microbiota composition analysis showing changes in bifidobacteria abundance following HMO supplementation in IBS patients. The data support HMO's ability to safely modulate fecal microbial populations." /> <figcaption>Figure 2. Gut microbiota composition analysis showing changes in bifidobacteria abundance following HMO supplementation in IBS patients. The data support HMO's ability to safely modulate fecal microbial populations.<br> Source: Cristina Iribarren et al. "The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profile." <em>Nutrients</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34836092/">34836092</a></figcaption> </figure>